Abstract
Viruses manipulate host cells to ensure their own survival and, at late stages of the viral life cycle, they kill the infected target cell to ensure their propagation. In addition, some viruses induce a bystander killing, a viral strategy to escape from the host's innate and cognate defense systems. In HIV-infection, the disabling of the immune system is initially due to the preferential depletion by apoptosis of virus-specific CD4+ T cells in lymphoid tissues, followed by the destruction of non-infected bystander cells. Both the extrinsic and the intrinsic pathways are activated, and this is the consequence of systemic immune activation. This review presents recent developments showing that the gastrointestinal tract is the major reservoir of infected cells and the site of rapid and profound loss of CD4 T cells, and that microbial translocation from the gastrointestinal tract is the cause of immune activation. Furthermore, apoptosis mechanisms involved in HIV-induced neuropathological disorders are discussed, including the role of syncytia that involve the sequential activation of ATM, p38MAPK and p53. Finally, HIV-associated dementia (HAD) was recently found in monkey models to be linked to inhibition of autophagy in neurons, suggesting that homeostasis of autophagy is a reliable security factor for neurons, and challenging the development of new therapeutics aimed at boosting neuronal autophagy to prevent HAD.
Similar content being viewed by others
References
Gougeon M-L (2005) To kill or be killed: how HIV exhausts the immune system. Cell Death Differ 12:845–854. doi:10.1038/sj.cdd.4401616
Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, Codogno P, Biard-Piechaczyk M (2006) Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 116:2161–2172. doi:10.1172/JCI26185
Spector SA, Zhou D (2008) Autophagy: an overlooked mechanism of HIV-1 pathogenesis and neuroAIDS? Autophagy 4:704–706
Douek DC, Brenchley JM, Betts MR et al (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95–98. doi:10.1038/417095a
Haase AT (2005) Peril at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5:783–792
Amendola A, Gougeon M-L, Poccia F, Bondurand A, Fesus L, Piacentini M (1996) Induction of “tissue” transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Proc Natl Acad Sci USA 93:11057–11062. doi:10.1073/pnas.93.20.11057
Muro-Cacho CA, Pantaleo G, Fauci AS (1995) Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154:5555–5566
Brenchley JM, Schacker TW, Ruff LE et al (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749–759. doi:10.1084/jem.20040874
Douek DC (2007) HIV disease progression: immune activation, microbes and a leaky gut. Top HIV Med 15:114–117
Li Q, Duan L, Estes JD, Ma ZM et al (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148–1152
Gougeon M-L (1995) Chronic activation of the immune system in HIV infection: contribution to T cell apoptosis and V beta selective T cell anergy. Curr Top Microbiol Immunol 200:177–193
Giorgi JV, Hultin LE, McKeating JA et al (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179:859–870. doi:10.1086/314660
Gougeon M-L, Lecoeur H, Boudet F, Ledru E, Marzabal S, Boullier S, Roué R, Nagata S, Heeney J (1997) Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol 158:2964–2976
Silvestri G, Paiardini M, Pandrea I et al (2007) Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117:3148–3154. doi:10.1172/JCI33034
Lane HC, Masur H, Edgar LC et al (1983) Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453–458
Gougeon M-L, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T, Montagnier L (1996) Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 156:3509–3520
Hazenberg MD, Stuart JW, Otto SA et al (2000) T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95:249–255
Ledru E, Lecoeur H, Garcia S, Debord T, Gougeon M-L (1998) Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 160:3194–3206
de Oliveira Pinto LM, Garcia S, Lecoeur H, Rapp C, Gougeon M-L (2002) Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood 99:1666–1675. doi:10.1182/blood.V99.5.1666
Moir S, Malaspina A, Pickeral OK et al (2004) Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 200:587–599. doi:10.1084/jem.20032236
Brenchley JM, Price DA, Schacker TW et al (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365–1371. doi:10.1038/nm1511
Bofill M, Gombert W, Borthwick NJ, Akbar AN, McLaughlin JE, Lee CA, Johnson MA, Pinching AJ, Janossy G (1995) Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients. Am J Pathol 146:1542–1555
Boudet F, Lecoeur H, Gougeon M-L (1996) Apoptosis associated with ex vivo down-regulation of bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 156:2282
Petrovas C, Mueller YM, Dimitriou ID, Bojczuk PM, Mounzer KC, Witek J, Altman JD, Katsikis PD (2004) HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J Immunol 172:4444–4453
Mueller YM, Petrovas C, Do DH, Altork SR, Fischer-Smith T, Rappaport J, Altman JD, Lewis MG, Katsikis PD (2007) Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects. J Virol 81:10861–10868. doi:10.1128/JVI.00813-07
Genescà M, Rourke T, Li J, Bost K, Chohan B, McChesney MB, Miller CJ (2007) Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239. J Immunol 179:4732–4740
Gougeon ML (2003) Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 3:392–404. doi:10.1038/nri1087
Hardy AW, Graham DR, Shearer GM, Herbeuval JP (2007) HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci USA 104:17453–17458. doi:10.1073/pnas.0707244104
Nardacci R, Antinori A, Larocca LM, Arena V, Amendola A, Perfettini JL, Kroemer G, Piacentini M (2005) Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis. Am J Pathol 167:695–704
Perfettini JL, Roumier T, Castedo M et al (2004) NF-{kappa}B and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. J Exp Med 199:629–640. doi:10.1084/jem.20031216
Perfettini JL, Castedo M, Nardacci R et al (2005) Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 201:279–289. doi:10.1084/jem.20041502
Piacentini M, Kroemer G (2005) Cell death pathways in retroviral infection. Cell Death Differ 12:835–836. doi:10.1038/sj.cdd.4401655
Perfettini JL, Nardacci R, Bourouba MG et al (2008) Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. PLoS ONE 3(6):e2458. doi:10.1371/journal.pone.0002458
Perfettini JL, Nardacci R, Séror C et al (2008) The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope. Cell Death Differ (Nov):21
Deeks SG, Walker BD (2007) Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27:406–416. doi:10.1016/j.immuni.2007.08.010
Betts MR, Nason MC, West SM et al (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781–4789. doi:10.1182/blood-2005-12-4818
Migueles SA, Laborico AC, Shupert WL et al (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3:1061–1068. doi:10.1038/ni845
Saez-Cirion A, Lacabaratz C, Lambotte O et al (2007) HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 104:6776–6781. doi:10.1073/pnas.0611244104
Appay V, Nixon DF, Donahoe SM et al (2000) HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192:63–75. doi:10.1084/jem.192.1.63
Champagne P, Ogg GS, King AS et al (2001) Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106–111. doi:10.1038/35065118
Day CL, Kaufmann DE, Kiepiela P et al (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350–354. doi:10.1038/nature05115
Petrovas C, Casazza JP, Brenchley JM et al (2006) PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203:2281–2292. doi:10.1084/jem.20061496
Trautmann L, Janbazian L, Chomont N et al (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12:1198–1202. doi:10.1038/nm1482
Gougeon M-L, Montagnier L (1993) Apoptosis in AIDS. Science 260:1269–1270. doi:10.1126/science.8098552
Meyaard L, Otto SA, Jonker RR et al (1992) Programmed death of T cells in HIV-1 infection. Science 257:217–219. doi:10.1126/science.1352911
Rawson PM, Molette C, Videtta M et al (2007) Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med 13:1431–1439. doi:10.1038/nm1679
Yorimitsu T, Klionsky DJ (2005) Autophagy: molecular machinery for self-eating. Cell Death Differ S2:1542–1552. doi:10.1038/sj.cdd.4401765
Schmid D, Münz C (2007) Innate and adaptive immunity through autophagy. Immunity 27:11–21. doi:10.1016/j.immuni.2007.07.004
Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A (2007) Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315:1398–1401. doi:10.1126/science.1136880
Denizot M, Varbanov M, Espert L (2008) HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 4:998–1008
Zhou D, Spector SA (2008) Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 22:695–699
Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9:1004–1010. doi:10.1038/nrm2529
Sarkar S, Rubinsztein DC (2008) Huntington’s disease: degradation of mutant huntingtin by autophagy. FEBS J 275:4263–4270. doi:10.1111/j.1742-4658.2008.06562.x
Fimia GM, Stoykova A, Romagnoli A et al (2007) Ambra1 regulates autophagy and development of the nervous system. Nature 447:1121–1125
Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69–81. doi:10.1038/nri1527
Alirezaei M, Kiosses WB, Fox HS (2008) Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 4:963–966
Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH (2006) Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade. J Exp Med 203:2223–2227. doi:10.1084/jem.20061800
Ledru E, Christeff N, Patey O, de Truchis P, Melchior JC, Gougeon ML (2000) Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome. Blood 95:3191–3198
Brass AL, Dykxhoorn DM, Benita Y et al (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921–926. doi:10.1126/science.1152725
Acknowledgments
This work was supported by grants from Sidaction and Agence Nationale de la Recherche (ANR no. 07-RARE-002-01) to MLG, Ricerca Corrente and Finalizzata from Ministero della Salute, AIRC, Telethon Foundation, EU integrated project “Apo-sys” to MP.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gougeon, ML., Piacentini, M. New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14, 501–508 (2009). https://doi.org/10.1007/s10495-009-0314-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-009-0314-1